|A Japanese funded project will transfer technology to help Viet Nam produce its own combined measles and rubella vaccine.— VNA/VNS Photo
HA NOI (VNS)— A Japanese funded project will transfer technology to help Viet Nam produce its own combined measles and rubella vaccine.
The work will be part of a US$7.51 million project that was signed yesterday between the Japan International Co-operation Agency (JICA) and Viet Nam's Centre for Research and Production of Vaccines.
The 5-year project is expected to begin next month. Japanese experts will come to Viet Nam to help transfer technology while Vietnamese researchers will receive training in Japan under the project.
A measles vaccine production facility, whose construction was funded by Japanese Grant Aid for the 2003-06 term, will be provided with new equipment to produce the new vaccine.
It is expected that by the end of 2017, Viet Nam will be capable of producing a combined measles-rubella vaccine, with possible exports of the vaccine to follow.
"With this WHO – GMP credited measles vaccine production facility, and with advanced Japanese technology, we believe that Viet Nam will be able to produce high quality measles and rubella vaccines to respond to domestic needs and also export the vaccine to neighbouring countries," said Chief Representative of JICA Viet Nam Office Tsuno Motonori.
"Once this purpose is achieved, we can help to protect children's health and eliminate the risk of children born with disabilities caused by mothers being affected by rubella in the first trimester of pregnancy."
Health sector statistics show that more than 4,000 pregnant women had rubella while more than 200 babies were born with congenital defects due to rubella in 2011. — VNS